Why the study?
Does voltage-dependent channel block by methanesulfonamide class III antiarrhythmic agents contribute to reverse use dependence in isolated guinea pig ventricular myocytes?
Does voltage-dependent channel block by methanesulfonamide class III antiarrhythmic agents contribute to reverse use dependence in isolated guinea pig ventricular myocytes?
Answers are grounded in this paper and cite their sources.
Voltage-dependent block does not explain reverse use-dependence; leaves open alternative mechanisms in class III antiarrhythmics.
Voltage-clamp experiments were performed on isolated guinea pig ventricular myocytes to examine the voltage dependence of delayed rectifier block by methanesulfonamide channel blockers. Voltage-dependent channel block, in which block decreases as membrane potential is made more positive, could contribute to the phenomenon of reverse use dependence, in which the magnitude of the drug-induced prolongation in action potential duration (APD) is inversely proportional to stimulation rate. To determine whether such a voltage dependence exists, concentration-response curves were generated for dofetilide, E-4031, sematilide, and D,L-sotalol at test potentials ranging from 0 to 60 mV. All agents blocked current in a manner consistent with selective blockade of the rapidly activating component of delayed rectifier current, IKr. The rank order of potency was E-4031 approximately dofetilide > sematilide > sotalol. Block of tail currents by this class of compounds was more potent after test potentials to +60 mV than after those < or = 0-10 mV. These data are inconsistent with voltage-dependent channel block being a contributing factor to reverse use-dependence and suggest that other mechanisms must be responsible for this phenomenon.
No takes yet. Share an insight, caveat, or question.
Krafte et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: